Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
ASSETS
Cash and due from banks	$ 498,496	$ 327,313
Interest-bearing cash and temporary investments	1,664,038	967,330
Total cash and cash equivalents	2,162,534	1,294,643
Investment securities
Equity and other, at fair value	76,995	72,959
Available for sale, at fair value	8,829,870	3,196,166
Held to maturity, at amortized cost	2,300	2,476
Loans held for sale	30,715	71,647
Loans and leases (at fair value: $275,140 and $285,581)	37,441,951	26,155,981
Allowance for credit losses on loans and leases	(440,871)	(301,135)
Net loans and leases	37,001,080	25,854,846
Restricted equity securities	179,274	47,144
Premises and equipment, net	338,970	176,016
Operating lease right-of-use assets	115,811	78,598
Goodwill	1,029,234	0
Other intangible assets, net	603,679	4,745
Residential mortgage servicing rights, at fair value	109,243	185,017
Bank-owned life insurance	680,948	331,759
Deferred tax asset, net	347,203	132,823
Other assets	665,740	399,800
Total assets	52,173,596	31,848,639
Deposits, Interest-bearing and Noninterest-bearing, Alternative [Abstract]
Non-interest-bearing	14,256,452	10,288,849
Interest-bearing	27,350,568	16,776,763
Total deposits	41,607,020	27,065,612
Securities sold under agreements to repurchase	252,119	308,769
Borrowings	3,950,000	906,175
Junior subordinated debentures, at fair value	316,440	323,639
Junior and other subordinated debentures, at amortized cost	107,895	87,813
Operating lease liabilities	130,576	91,694
Other liabilities	814,512	585,111
Total liabilities	47,178,562	29,368,813
COMMITMENTS AND CONTINGENCIES (NOTE 18)
SHAREHOLDERS' EQUITY
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	5,802,747	3,450,493
Accumulated deficit	(467,571)	(543,803)
Accumulated other comprehensive loss	(340,142)	(426,864)
Total shareholders' equity	4,995,034	2,479,826
Total liabilities and shareholders' equity	52,173,596	31,848,639
Preferred Stock, Value, Issued	$ 0	$ 0
Preferred Stock, Shares Authorized	0
Preferred Stock, Shares Issued	0
Preferred Stock, Shares Authorized	2,000,000
Common Stock, Shares Authorized	520,000,000	238,320,000	[1]

[1] Periods prior to February 28, 2023 have been restated as a result of the adjustment to common shares outstanding based on the exchange ratio from the Merger of 0.5958.